Pharm Exec5d
FDA Approves Two Generics from Amneal Pharmaceuticals for Alzheimer and Oncology, with Tentative Approval for Gastrointestinal Disease
As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...
Amneal gets FDA approval for memantine/donepezil extended-release capsules
Amneal Pharmaceuticals (AMRX) announced that the FDA has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which ...